Commercial Intelligence for the Pharma and Medical Device Industries
Evaluate provides consensus forecasts, product pipelines, company financials, deal records and other trusted commercial intelligence to industry-leading companies of all sizes, including the majority of the top 100 pharma companies. Our online subscription services deliver a seamless view of the global market in a single, standardized platform, giving our clients the time and understanding to make the right strategic decisions for their company.
- MassBio members get a special rate for access to the industry-leading EvaluatePharma® service
- Additional data options include epidemiology data, European and Japanese drug forecasts, and EvaluatePharma Vision – the first single view of R&D risk and reward, including success rates, R&D costs, clinical timelines and outcomes, an NPV valuation platform and a calendar of market catalysts
- Company-wide, complimentary access to Vantage – award-winning, daily news and analysis on the industry events that matter
- Complimentary industry reports: http://www.evaluate.com/thought-leadership
- Quick Start needs analysis and personalized onboarding to support your business objectives
- Access to Evaluate’s best-in-class Client Success experts for the partnering that drives continued learning and maximizes value